The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery

PURPOSE: To evaluate the efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace (0–5 cells) anterior chamber cells, following cataract surgery with posterior chamber intraocular lens implantation. METHODS: The study designed employed two Phase III, double-masked,...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverstein, Steven M, Jackson, Mitchell A, Goldberg, Damien F, Muñoz, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037304/
https://www.ncbi.nlm.nih.gov/pubmed/24876763
http://dx.doi.org/10.2147/OPTH.S60292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037304/
https://www.ncbi.nlm.nih.gov/pubmed/24876763
http://dx.doi.org/10.2147/OPTH.S60292

Ejemplares similares